Pylixa 25 mg. 50 mg. 75 mg. 100 mg. 150 mg Capsules. hard
PDF Leaflet Revision Date: 23 February 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of neuropathic pain due to Herpes zoster and diabetes in adults.
Dosage (summary)
Starting dose: 75 mg twice daily; may increase to 150 mg twice daily after 3-7 days.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Not recommended during pregnancy; breastfeeding not advised due to excretion in milk.
Key Drug Interactions
- CNS depressants (e.g., opioids, lorazepam, ethanol)
Contraindications
- Hypersensitivity to pregabalin or excipients
Common side effects
- Dizziness
- Somnolence
- Blurred vision
- Weight gain
Counselling Points
- Avoid driving until effects are known.
- Monitor for signs of misuse or dependence.
- Gradual discontinuation recommended.
Serious warnings
- Risk of suicidal ideation
- Withdrawal symptoms upon discontinuation
- Caution in elderly and those with cardiovascular issues
Important Disclaimer
The Pylixa 25 mg. 50 mg. 75 mg. 100 mg. 150 mg Capsules. hard professional information leaflet below is the property of Spear Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
